STING Drives Psoriatic Inflammation by Promoting Neutrophil Recruitment and Facilitating NETosis
Immunology · 2026-07 · 178 (3) · 439-454
DOI: 10.1111/imm.70130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, online erschienen am 03.03.2026. Verfasst von Haoyun Luo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology and Plastic Surgery Center, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Extracellular Traps, Neutrophil Infiltration, Neutrophils, Psoriasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Medical Youth Top-Talent Project in Chongqing.
Abstract (Originalsprache)
Psoriasis is a chronic, immune‐mediated inflammatory disorder in which neutrophils are central to pathogenesis. While recent studies have implicated the cyclic GMP‐AMP synthase–stimulator of interferon genes (cGAS‐STING) pathway in psoriasis, its specific role in neutrophil‐mediated inflammation remains unclear. To investigate neutrophil function in psoriasis, we integrated single‐cell RNA‐seq from human lesions with studies in IMQ‐treated mouse models (wild‐type, STING−/−, PADi4−/−) and HL‐60 cells. We employed transcriptomic, cytometric and functional assays to assess neutrophil recruitment, cytokine secretion and neutrophil extracellular trap (NET) formation. Our study revealed significant upregulation of STING expression in both lesional and peripheral blood neutrophils of psoriasis patients. In the IMQ‐induced mouse model, STING knockout markedly alleviated disease severity, reduced neutrophil infiltration and suppressed IL‐1β release. Mechanistically, STING promoted neutrophil chemotactic migration via the IRF3/NF‐κB axis while directly regulating the formation of NETs in neutrophils and the release of cytotoxic mediators. Besides, distinct mouse strains exhibited significant differences in STING pathway activation, indicating genetic heterogeneity in the immunoregulatory mechanisms underlying psoriasis. Collectively, the above findings indicated that STING signalling in neutrophil‐mediated psoriatic inflammation not only regulates cell recruitment but also directly drives the terminal effector function of NETs production. Furthermore, strain‐specific differences suggest that the regulation of this pathway in the disease context is complex and context‐dependent, potentially influencing individualised therapeutic responses. Targeting the STING pathway could serve as a therapeutic strategy to simultaneously inhibit multiple pathogenic processes mediated by neutrophils.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology and Plastic Surgery Center, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Dermatology, Chongqing University Three Gorges Hospital, School of Medicine, Chongqing University, Chongqing, China.
ORCID-Profile: Haoyun Luo, Bangtao Chen
Förderung
- National Natural Science Foundation of China
- Medical Youth Top-Talent Project in Chongqing
Zitieren
APA
Luo, H., Hu, C., Tian, T., Qian, T., Jiang, X., Dang, Y., Chen, B., Yang, Z., Luo, N., Zhang, D., & Hao, F. (2026). STING Drives Psoriatic Inflammation by Promoting Neutrophil Recruitment and Facilitating NETosis. Immunology, 178(3), 439-454. https://doi.org/10.1111/imm.70130
Vancouver
Luo H, Hu C, Tian T, Qian T, Jiang X, Dang Y, et al. STING Drives Psoriatic Inflammation by Promoting Neutrophil Recruitment and Facilitating NETosis. Immunology. 2026;178(3):439-454. doi:10.1111/imm.70130
BibTeX
@article{Luo2026,
author = {Luo, Haoyun and Hu, Chenmin and Tian, Tian and Qian, Tian and Jiang, Xia and Dang, YongChao and Chen, Bangtao and Yang, Zhi and Luo, Na and Zhang, Daojun and Hao, Fei},
title = {STING Drives Psoriatic Inflammation by Promoting Neutrophil Recruitment and Facilitating NETosis},
journal = {Immunology},
year = {2026},
volume = {178},
number = {3},
pages = {439--454},
doi = {10.1111/imm.70130}
}
EUVIMED